The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
BIOLUMA: A phase II trial of nivolumab in combination with ipilimumab to evaluate efficacy and safety in lung cancer and to evaluate biomarkers predictive for response—Preliminary results from the NSCLC cohort.
 
Rieke Nila Fischer
Honoraria - Bristol-Myers Squibb; MSD; Roche
Research Funding - Bristol-Myers Squibb (Inst); MSD (Inst)
Travel, Accommodations, Expenses - Mediolanum Farmaceutici
 
Julie George
Stock and Other Ownership Interests - Foundation Medicine (I); Merck (I)
 
Andreas H. Scheel
Honoraria - Bristol-Myers Squibb; Dako/Agilent Technologies; MSD; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Dako/Agilent Technologies; MSD; Roche
 
Hans Anton Schloesser
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb
 
Maria Vehreschild
Honoraria - Akademie für Infektionsmedizin; Arztekammer Nordrhein; Astellas Pharma; Basilea; Gilead Sciences; Merck; Organobalance; Pfizer
Consulting or Advisory Role - Alcobra; Arderypharm; Astellas Pharma; Berlin-Chemie; Da Volterra; MaaT Pharma; Merck
Speakers' Bureau - Akademie für Infektionsmedizin; Akademie für Infektionsmedizin; Arztekammer Nordrhein; Astellas Pharma; Basilea; Gilead Sciences; Merck; Pfizer
Research Funding - 3M; Astellas Pharma; Da Volterra; Gilead Sciences; MaaT Pharma; Merck; Morphochem; Organobalance; Seres Therapeutics; Uniklinik Freiburg / Kongress und Kommunikation
 
Peter Brossart
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Roche
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Walburga Engel-Riedel
No Relationships to Disclose
 
Frank Griesinger
Honoraria - Abbvie; Boehringer Ingelheim; Bristol-Myers Squibb; Ipsen; MSD; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; MSD; Novartis; Pfizer; Roche/Genentech; Takeda
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Takeda (Inst)
 
Christian Grohé
Honoraria - Abbvie; AstraZeneca; Boehringer Ingelheim; Lilly; MSD Oncology; Novartis; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; MSD Oncology
Research Funding - Abbvie (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Roche
 
Karl-Otto Kambartel
No Relationships to Disclose
 
Jens Kern
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; MSD; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; MSD; Pfizer; Roche
 
Barbara Hermes
Research Funding - Bayer; Bristol-Myers Squibb; Lilly; MSD; Novartis; Roche Pharma AG
Travel, Accommodations, Expenses - Lilly; PharmaMar
 
Kathrin Nachtkamp
Honoraria - BSH Medical Communications; Jazz Pharmaceuticals
Travel, Accommodations, Expenses - Celgene
 
Jens Peter Panse
Honoraria - Alexion Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Hexal; Novartis; Pfizer; Roche
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Hexal; Novartis; Pfizer; Roche
Speakers' Bureau - Alexion Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Hexal; Novartis; Pfizer; Roche
 
Martin Sebastian
Honoraria - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer/EMD Serono; Roche/Genentech; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; MSD; Novartis; Pfizer; Roche/Genentech; Takeda
Travel, Accommodations, Expenses - Pfizer; Takeda
 
Markus Lehmann
No Relationships to Disclose
 
Rainer Gerhard Wiewrodt
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Grifols; Lilly; Novartis; Roche; Takeda
Speakers' Bureau - Abbvie; Bayer; Boehringer Ingelheim; CLS; GlaxoSmithKline; Lilly; MSD; Novartis; Pfizer; Roche; UKM Academy
Research Funding - Abbvie; Boehringer Ingelheim; MSD; Roche
 
Reinhard Büttner
Employment - Targos GmbH
Leadership - Targos GmbH
Stock and Other Ownership Interests - Targos GmbH
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Pfizer; Roche
Expert Testimony - MSD
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
 
Roman K. Thomas
No Relationships to Disclose
 
Juergen Wolf
Honoraria - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis; Roche
Consulting or Advisory Role - Abbvie; AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Ignyta; Janssen; Lilly; Loxo/Lilly; MSD Oncology; Novartis; Pfizer; Roche
Research Funding - Bristol-Myers Squibb; Janssen; Novartis; Pfizer